Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
45.66
-0.32 (-0.70%)
At close: Jul 15, 2026, 4:00 PM EDT
45.58
-0.08 (-0.18%)
After-hours: Jul 15, 2026, 4:47 PM EDT
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Reiterates $63 | Buy | Reiterates | $63 | +37.98% | Jul 15, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $30 → $60 | Buy | Reiterates | $30 → $60 | +31.41% | Jul 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $60 → $58 | Buy | Reiterates | $60 → $58 | +27.03% | Jun 30, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +9.51% | Jun 23, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $61 → $74 | Buy | Reiterates | $61 → $74 | +62.07% | Jun 23, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $37 → $57 | Buy | Maintains | $37 → $57 | +24.84% | Jun 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +53.31% | Jun 22, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $60 | Buy | Maintains | $40 → $60 | +31.41% | Jun 22, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.